Metabolic stroke in methylmalonic acidemia five years after liver transplantation.

Authors:
Anupam Chakrapani
Anupam Chakrapani
Birmingham Children's Hospital
United Kingdom

J Pediatr 2002 Feb;140(2):261-3

Liver Unit, Birmingham Children's Hospital, United Kingdom.

It is believed that liver transplantation may improve the outcome of early onset methylmalonic acidemia. We report a case of methylmalonic acidemia in which successful liver transplantation in infancy failed to prevent neurologic damage caused by a metabolic stroke.

Download full-text PDF

Source
http://dx.doi.org/10.1067/mpd.2002.121698DOI Listing
February 2002
5 Reads

Publication Analysis

Top Keywords

methylmalonic acidemia
12
liver transplantation
12
metabolic stroke
8
case methylmalonic
4
acidemia successful
4
report case
4
acidemia report
4
outcome early
4
onset methylmalonic
4
successful liver
4
infancy failed
4
damage caused
4
caused metabolic
4
neurologic damage
4
prevent neurologic
4
improve outcome
4
failed prevent
4
transplantation infancy
4
early onset
4
transplantation believed
4

Similar Publications

Current role of liver transplantation for methylmalonic acidemia: a review of the literature.

Pediatr Transplant 2006 Dec;10(8):943-7

Department of Transplant Surgery, National Center for Child Health and Development, Tokyo, Japan.

To evaluate the current role of liver transplantation (LT) for methylmalonic acidemia (MMA), we reviewed the literature on outcomes of this treatment, and describe three of our own cases of living-donor liver transplantation (LDLT). The total number of LT cases identified was 18. Transplantation mode was deceased donor LT in 12, including five combined liver-kidney transplantations (CLKT) from deceased donors, and LDLT in six. Read More

View Article
December 2006

Efficacy of living donor liver transplantation for patients with methylmalonic acidemia.

Am J Transplant 2007 Dec 1;7(12):2782-7. Epub 2007 Oct 1.

Department of Transplant Surgery, National Center for Child Health and Development, Tokyo, Japan.

Application of liver transplantation to methylmalonic acidemia (MMAemia) is controversial because MMAemia is caused by a systemic defect of methylmalonyl-CoA mutase. The clinical courses of seven pediatric patients with MMAemia undergoing living donor liver transplantation (LDLT) were reviewed. Serum and urinary methylmalonic acid (MMA) levels were found to be significantly decreased after LDLT, whereas serum and urinary MMA levels did not return to normal in any patient. Read More

View Article
December 2007

Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation.

Pediatr Transplant 2010 May 14;14(3):337-41. Epub 2009 Aug 14.

Department of Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Methylmalonic acidemia with complete mutase deficiency (mut(0) type) is an inborn error of metabolism with high mortality and morbidity. LT has been suggested to be a solution to this disease, but elevation of urinary and blood MMA was still observed after LT. In this study, we measured dry blood spot MMA and its precursor propionyl-carnitine (C3-carnitine) for mut(0) patients. Read More

View Article
May 2010

Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver.

Eur J Pediatr 2002 Jul 5;161(7):377-9. Epub 2002 Jun 5.

UCSD Pediatrics (0830), 9500 Gilman Drive, La Jolla, CA 92093-0830, USA.

Unlabelled: Methylmalonic acidemia unresponsive to cobalamin is often fatal in infancy. Patients have been considered candidates for hepatic transplantation and experience has been that the procedure eliminates the life-threatening episodes of ketoacidosis that characterize this disease.

Conclusion: experience with a 24-year-old patient treated with hepatic transplantation indicates that this procedure does not prevent progressive renal failure and neurologic dysfunction. Read More

View Article
July 2002